Jo Caers

15PUBLICATIONS
56CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 23, 2026
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.

|Oct 07, 2025
Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.

Isabelle Bergiers, Murat Cem Köse, Sheri Skerget

|Nov 05, 2024
CD38 as theranostic target in oncology.

Valentina Bocuzzi, Jessica Bridoux, Michelle Pirotte

|Feb 23, 2023
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel.

Xavier Leleu, Eirini Katodritou, Thomas Kuehr

|May 05, 2022
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.

Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro

|Mar 22, 2022
Extramedullary disease in multiple myeloma: a systematic literature review.

Joan Bladé, Meral Beksac, Jo Caers

Pageof 3

Frequent Collaborators

2 joint publications

Laura Rosiñol

2 joint publications

Pieter Sonneveld

2 joint publications

Fredrik Schjesvold

1 joint publications

Erwan Plougonven